12:00 AM
Jul 05, 2010
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Rexahn completes direct public offering

Rexahn Pharmaceuticals Inc. (NYSE-A:RNN), Rockville, Md.
Business: Cancer, Neurology, Genitourinary
Date completed: 6/28/10
Type: Direct public...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >